Part 1, Volume 160 #47
Highlights
- Proposed: rubber product manufacturing release guidelines would add MBT and precursors, with a 2.1 µg/L MBT concentration target; comments due January 20, 2027.
- Final: Bank of Canada designated Real-Time Rail as a clearing and settlement system under the Payment Clearing and Settlement Act, effective November 8, 2026.
- Final: Finance designated Financial Data Exchange Inc. as the Consumer-Driven Banking Act technical standards body and OBSI as the external complaints body, both on November 13, 2026.
- Fees: Health Canada drug and medical device fees rise by CPI of 2.8% effective April 1, 2027, including Class IV medical device licence applications from $30,713 to $31,573.
- Fees: Health Canada dealer’s licences, Drug Master Files, Certificates of Pharmaceutical Product and Certificate of Supplementary Protection fees increase effective April 1, 2027; CSP fee rises from $10,776 to $10,992.
- Trade remedy: CBSA extended preliminary investigations into alleged dumping and subsidization of paperboard cups and containers from China to 135 days; decisions due by December 30, 2026.
- Energy: CER seeks comments on IESO’s application to export up to 4,000 MW of emergency firm power to the U.S. for 10 years starting March 1, 2027; submissions due December 7, 2026.
- Trade remedy: CITT continued the heavy plate finding for Chinese Taipei and Germany in expiry review RR-2025-007; order dated November 10, 2026.
Paperboard cups dumping investigation extended and more
Paperboard cups and containers — Canada Border Services Agency: decision extending, under subsection 39(1) of the Special Import Measures Act, the preliminary phase of investigations into alleged injurious dumping and subsidization of paperboard cups and containers originating in or exported from the People’s Republic of China. The period is extended from 90 days to 135 days due to complexity or novelty, number of persons involved and difficulty obtaining satisfactory evidence; preliminary determinations or termination decisions will be made on or before December 30, 2026.
Independent Electricity System Operator emergency electricity exports — Canada Energy Regulator: consultation on an application dated November 6, 2026, for authorization under Division 2 of Part 7 of the Canadian Energy Regulator Act to export on an emergency basis up to 4 000 MW of firm power and energy to the United States for 10 years commencing March 1, 2027. Interested-party submissions must address, among other things, effects on provinces other than the exporting province and whether Canadian buyers were informed and given an opportunity to buy on equally favourable conditions; submissions due December 7, 2026, and any Applicant answer due December 22, 2026.
Refined sugar — Canadian International Trade Tribunal: notice of revised expiry review RR-2026-004 under subsection 76.03(1) of the Special Import Measures Act of orders concerning dumping of refined sugar originating in or exported from the United States of America, Denmark, the Federal Republic of Germany, the Netherlands and the United Kingdom, and subsidizing of those goods originating in or exported from the European Union. The CBSA will determine whether expiry is likely to result in continuation or resumption of dumping or subsidizing no later than November 27, 2026; the Tribunal will issue its orders and reasons no later than May 6, 2027; notices of participation, representation, declaration and undertaking were due July 17, 2026; record distribution is January 19, 2027; hearing during the week of March 1, 2027.
Certain grinding media — Canadian International Trade Tribunal: notice of revised expiry review RR-2026-005 under subsection 76.03(1) of the Special Import Measures Act of the August 27, 2021 finding in inquiry NQ-2021-001 concerning dumping and subsidizing of chrome cast iron grinding media in spherical or ovoid shape, diameter 12.7 millimetres (½ inch) to and including 76.2 millimetres (3 inches), tolerances of 5 percent (5%), alloy composition 10 percent or more chromium, produced through casting, originating in or exported from the Republic of India; goods imported for use in cement production facilities are excluded. The CBSA will determine likelihood of continuation or resumption no later than December 31, 2026; the Tribunal will issue its order and reasons no later than June 9, 2027; notices of participation, representation, declaration and undertaking were due August 19, 2026; record distribution is February 23, 2027; hearing during the week of April 5, 2027.
Heavy plate — Canadian International Trade Tribunal: order in expiry review RR-2025-007 continuing, pursuant to paragraph 76.03(12)(b) of the Special Import Measures Act, the finding in respect of heavy plate originating or exported from the Separate Customs Territory of Taiwan, Penghu, Kinmen, and Matsu (Chinese Taipei) and the Federal Republic of Germany. Certain products are excluded as described in the Tribunal’s order; order dated November 10, 2026.
Building maintenance services procurement — Canadian International Trade Tribunal: decision in file PR-2026-029 determining that a complaint by AV-TECH INC. concerning National Research Council of Canada solicitation 25-58200 for electromechanical maintenance services, renovation and minor construction work was valid, in part. AV-TECH alleged unfair solicitation and bid evaluation, unclear documents, and failure to comply with the Buy Canadian Policy and the Policy on Prioritizing Canadian Suppliers and Canadian Content in Strategic Federal Procurements; determination dated November 10, 2026.
Consumer electronics procurement — Canadian International Trade Tribunal: decision in file PR-2026-011 determining that a complaint by WesTower Communications Ltd. concerning Public Works and Government Services solicitation WS5454524515, issued on behalf of the Department of National Defence for repair and overhaul of strategic tower, antenna and cable systems, was not valid. WesTower alleged unclear, ambiguous and incoherently applied bid criteria; determination dated August 10, 2026.
Also: 67 Canada Revenue Agency charity registration revocation notices. [Source]
Real-Time Rail designated payments clearing system and more
Real-Time Rail designation — Bank of Canada: final (made or in force). The Governor of the Bank of Canada designated the Real-Time Rail (RTR), operated by the Canadian Payments Association (Payments Canada), as a clearing and settlement system subject to Part I of the Payment Clearing and Settlement Act under subsection 4(1), because the RTR could be operated in a manner that poses a payments system risk and the Minister of Finance is of the opinion that designation is in the public interest. The RTR provides continuous clearing and settlement of payments with immediate availability of funds and will serve as the clearing and settlement system for Interac e-Transfer. Designation is effective November 8, 2026.
Financial Data Exchange Inc. designated technical standards body — Department of Finance: final (made or in force). The Minister of Finance designated Financial Data Exchange Inc., acting through its FDX Canada Council, as the technical standards body under subsection 125(1) of the Consumer-Driven Banking Act, responsible for establishing the technical standard used for sharing data by participating entities under that Act. The designation was made at Ottawa, November 13, 2026.
Ombudsman for Banking Services and Investments designated external complaints body — Department of Finance: final (made or in force). On the recommendation of the Bank of Canada, the Minister of Finance designated the Ombudsman for Banking Services and Investments, a corporation incorporated under the Canada Not-for-profit Corporations Act, as the external complaints body referred to in subsection 114(1) of the Consumer-Driven Banking Act. The designation was made at Ottawa, November 13, 2026.
Annual adjustment of Fees in Respect of Drugs and Medical Devices Order — Department of Health: notice. Health Canada gives notice under subsection 30.61(1) of the Food and Drugs Act that every fee in the 2020 Fees in Respect of Drugs and Medical Devices Order is adjusted annually based on the Consumer Price Index (CPI), rounded up to the nearest dollar; the CPI for this year is 2.8%. Updated fees apply as of April 1, 2027, except biocide tables show fees as of May 31, 2026 and April 1, 2027. Examples include human drug submission review: “New active substance” from $616,593 to $633,858; “Clinical or non-clinical data and chemistry and manufacturing data” from $319,282 to $328,222; “Administrative submission” from $1,020 to $1,049. Drug establishment licence fees for human use include “Fabrication — sterile dosage form” from $50,401 to $51,813 and “Importation” from $38,916 to $40,006. Medical device fees include “Applications for Class IV licence” from $30,713 to $31,573, “Medical device” establishment licence from $5,519 to $5,674, and right to sell licensed Class II, III or IV medical devices from $460 to $473. Biocide application fees include “Biocide full review — novel biocide” from $42,394 to $43,582 and right to sell “Biocide” from $1,562 to $1,606. Inquiries or comments may be directed to Rosslynn Miller-Lee, 613‑327‑0798 or cro-brc@hc-sc.gc.ca; no comment deadline is stated.
Annual adjustment of fees for dealer’s licences — Department of Health: notice. Health Canada gives notice under section 19.2 of the Financial Administration Act that the fee for dealer’s licences: human drugs will increase by the annual 2% amount, rounded up to the nearest dollar, and the dealer’s licence: veterinary drugs will be adjusted by the CPI under subsection 17(1) of the Service Fees Act; Health Canada selected April 1 as the anniversary date and the CPI for this year is 2.8%. As of April 1, 2027, “Dealer’s licence (human drugs)” increases from $6,078 to $6,200; “Dealer’s licence (veterinary drugs)” from $2,192.31 to $2,253.69; and “Dealer’s licence (veterinary drugs, first year)” from $1,096.16 to $1,126.85. Inquiries or comments may be directed to Rosslynn Miller-Lee, 613‑327‑0798 or cro-brc@hc-sc.gc.ca; no comment deadline is stated.
Annual increase of Drug Master Files and Certificate of Pharmaceutical Product fees — Department of Health: notice. Health Canada gives notice that, under the Ministerial Authority to Enter into Contract, fees payable for Drug Master Files and Certificate of Pharmaceutical Product services are updated by 2%, rounded up to the nearest dollar. As of April 1, 2027, “Certificate of Pharmaceutical Product (or a supplemental copy of a Certificate of Pharmaceutical Product)” increases from $105 to $108; “New Master Files (file registration)” from $1,436 to $1,465; “Drug Master Files — letter of access” from $204 to $209; and “Drug Master Files — update” from $624 to $637. Inquiries or comments may be directed to Rosslynn Miller-Lee, 613‑327‑0798 or cro-brc@hc-sc.gc.ca; no comment deadline is stated.
Annual increase of Certificate of Supplementary Protection fee — Department of Health: notice. Health Canada gives notice that, under subsection 9(1) of the Certificate of Supplementary Protection Regulations, the Certificate of Supplementary Protection fee will increase by the annual 2% amount, rounded up to the nearest dollar. As of April 1, 2027, the fee increases from $10,776 to $10,992. Inquiries or comments may be directed to Rosslynn Miller-Lee, 613‑327‑0798 or cro-brc@hc-sc.gc.ca; no comment deadline is stated.
Also: Governor in Council appointment opportunities posted for President and Chief Executive Officer, Atomic Energy of Canada Limited, closing November 19, 2026; Director, Canadian Tourism Commission, closing December 7, 2026; Member, Immigration and Refugee Board, closing November 26, 2026; Governor, International Development Research Centre, closing December 10, 2026; Member — All Divisions, Parole Board of Canada, closing November 24, 2026; and Vice-Chairperson, Social Security Tribunal of Canada, closing November 26, 2026. [Source]
MBT added to proposed rubber manufacturing release guidelines
Proposed Amendments to the Release Guidelines for Chemicals Used in the Rubber Product Manufacturing Sector — Department of the Environment: proposed (open for comment). Under subsection 54(1) of the Canadian Environmental Protection Act, 1999, the Minister of the Environment proposes to amend the Release Guidelines for Chemicals Used in the Rubber Product Manufacturing Sector to add 2-mercaptobenzothiazole (MBT) and its precursors as substances of concern for facilities that use them and release industrial effluent containing them. The amendments would add an “MBT moiety” definition; set an MBT concentration target of 2.1 µg/L; set a minimum reporting limit for MBT of 0.21 µg/L and for BENPAT of 0.043 µg/L; add MBT-specific reporting calculations, including mass fractions for TBBS 0.70, CBS 0.63, MBTS 1.0, MBT 1.0, DCBS 0.48, SMBT 0.88, MMBT 0.59, TBSI 0.83 and MOR 0.66; and add default assumptions for MBT and its precursors of L = 0.0003, RRon = 0.10 for on-site pre-treatment removal or 0.62 for secondary treatment, and RRoff = 0.62 for secondary treatment. A standardized analytical method for MBT in water is under development and is expected to be completed prior to final publication of the amended Guidelines; effluent sampling for MBT and its precursors will apply once that method is finalized. Affected facilities should submit a Declaration of the operator for MBT and its precursors within six (6) months of the date of the final amendments if already using them, or within six (6) months of initial use if use starts after the final amendments; the first annual report for MBT and its precursors would be due by June 1, 2029, for the 2028 calendar year. Comments due January 20, 2027 (60 days), to pgpc-dppc-cmp-cpd@ec.gc.ca. [Source]